Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
OTCMKTS · Delayed Price · Currency is USD
2.670
0.00 (0.00%)
At close: Jul 28, 2025
SFOSF Market Cap
SFOSF has a market cap or net worth of $9.32 billion as of August 1, 2025. Its market cap has increased by 24.76% in one year.
Market Cap
9.32B
Enterprise Value
13.91B
Revenue
5.56B
Ranking
n/a
PE Ratio
23.12
Stock Price
$2.67
Market Cap Chart
Since August 9, 2005, SFOSF's market cap has increased from 539.79M to 9.32B, an increase of 1,626.81%. That is a compound annual growth rate of 15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 9.32B | 13.87% |
| Dec 31, 2024 | 8.19B | -5.76% |
| Dec 29, 2023 | 8.69B | -31.08% |
| Dec 30, 2022 | 12.60B | -29.69% |
| Dec 31, 2021 | 17.92B | -6.98% |
| Dec 31, 2020 | 19.27B | 106.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |